Engineered M2-sEV encapsulated Se-mRh nanoparticles with Fe2+ chelating capability inhibit ferroptosis for Alzheimer's disease treatment

Key Points

• Inhibition of ferroptosis was observed, showing potential therapeutic effects in Alzheimer's disease.
• The engineered M2-sEV encapsulated Se-mRh nanoparticles effectively chelate Fe2+, reducing oxidative stress.
• Analysis was conducted using innovative nanoparticle technology to assess cellular responses in Alzheimer’s models.
• This approach highlights the potential role of ferroptosis inhibition in therapy; further validation is necessary.